Koyfin Home > Directory > Health Care > Acceleron Pharma > Return on Equity %

Acceleron Pharma Return on Equity % Chart (XLRN)

Acceleron Pharma annual/quarterly Return on Equity % from 2013 to 2020.
  • Acceleron Pharma Return on Equity % for the quarter ending June 06, 2020 was -17.67 a -112.95% increase of 19.96 year over year
  • Acceleron Pharma Return on Equity % for the last 12 months ending June 06, 2020 was -30.02 a -15.58% increase of 4.68 year over year
  • Acceleron Pharma Annual Return on Equity % for 2019 was -33.68 a -7.41% increase of 2.50 from 2018
  • Acceleron Pharma Annual Return on Equity % for 2018 was -36.17 a -1.50% increase of 0.54 from 2017
  • Acceleron Pharma Annual Return on Equity % for 2017 was -36.71 a 7.25% decrease of -2.66 from 2016
Other Margins & Efficiency Metrics:
  • Acceleron Pharma EBITDA Margin for the quarter ending March 03, 2016 was $-20m a -39.99% increase of 8m year over year
  • Acceleron Pharma Return on Capital % for the quarter ending September 09, 2018 was -23.05 a 14.16% decrease of -3.26 year over year
View Chart On Koyfin

Quarterly XLRN Return on Equity % Data

06/2020-17.67
03/2020-47.20
12/2019-20.63
09/2019-37.62
06/2019-14.14
03/2019-37.93
12/2018-45.47
09/2018-35.54
06/2018-33.70
03/2018-29.17

Annual XLRN Return on Equity % Data

2019-33.68
2018-36.17
2017-36.71
2016-34.05
2015-48.12
2014-47.88
2013-118.78
2012590.41